Safety is the issue of the day across American workplaces, and we have another resource to help you upgrade your safety protocols. Our most recent webinar—Drug Testing: Essential and Smart During the Ongoing COVID-19 Pandemic (download it here)—underscored the link between employer drug testing programs and the increased safety challenges of the coronavirus crisis.
Most importantly, the event outlined how to respond to the added risk of substance abuse in today’s unprecedented environment.
Studies have shown that the misuse of alcohol and illegal drugs, particularly marijuana, rises during national crises. Sadly, the COVID-19 pandemic presents an unprecendented situation which employers and their teams have probably not had to confront. Americans are dealing with worries about their families’ health, isolation from loved ones and support networks due to social distancing, concerns about job stability and layoffs affecting their households, and so much more.
Employers must be ready to intervene effectively to maintain the high level of workplace safety that all of their stakeholders have come to expect. This may require a new look at drug testing policies.
Fortunately, Asurint was able to secure 30-year drug testing industry veteran and author of the book Why Drug Testing?, Bill Current, to walk webinar participants through the most pressing issues and help find solutions for their workplaces. Last month's event was full of information about:
This moment calls on all of us to do more to safeguard others. So if you need additional assistance to align a drug testing program with your organization’s larger safety mission and COVID-19 response measures, please don’t hesitate to contact us at 800-906-2035 or drop us a line here. We’d be happy to help!
Most importantly, the event outlined how to respond to the added risk of substance abuse in today’s unprecedented environment.
Studies have shown that the misuse of alcohol and illegal drugs, particularly marijuana, rises during national crises. Sadly, the COVID-19 pandemic presents an unprecendented situation which employers and their teams have probably not had to confront. Americans are dealing with worries about their families’ health, isolation from loved ones and support networks due to social distancing, concerns about job stability and layoffs affecting their households, and so much more.
Employers must be ready to intervene effectively to maintain the high level of workplace safety that all of their stakeholders have come to expect. This may require a new look at drug testing policies.
Fortunately, Asurint was able to secure 30-year drug testing industry veteran and author of the book Why Drug Testing?, Bill Current, to walk webinar participants through the most pressing issues and help find solutions for their workplaces. Last month's event was full of information about:
- Current trends and forecasts about substance abuse during the coronavirus pandemic, along with the consequences for workplace safety and productivity
- Tips for building or updating a strong, legally compliant drug testing program and integrating it with other safety practices, such as COVID-19 testing
- Best practices for COVID-19 safety and ways to prepare for a post-pandemic workplace
This moment calls on all of us to do more to safeguard others. So if you need additional assistance to align a drug testing program with your organization’s larger safety mission and COVID-19 response measures, please don’t hesitate to contact us at 800-906-2035 or drop us a line here. We’d be happy to help!